(267 days)
Not Found
No
The document describes a physical medical device (anesthesia needles) and its performance testing, with no mention of software, algorithms, or AI/ML capabilities.
Yes.
The device is used to administer an anesthetic agent to the subarachnoid space, which is a therapeutic intervention aimed at pain management.
No
This device is an anesthesia conduction needle used to administer anesthetic agents, not to diagnose a condition.
No
The device description clearly outlines physical components made of materials like Stainless Steel and Polycarbonate, and the performance studies focus on mechanical properties and material testing, indicating it is a hardware device.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is to "administer anesthetic agent to the subarachnoid space." This is a therapeutic procedure, not a diagnostic one. IVD devices are used to examine specimens derived from the human body to provide information for diagnostic, monitoring, or compatibility purposes.
- Device Description: The device is a needle used for delivering a substance into the body. It does not involve the analysis of biological samples.
- Lack of IVD Characteristics: The description does not mention any components or functions related to analyzing biological specimens (e.g., reagents, test strips, analytical software).
- Performance Studies: The performance studies focus on the physical properties and functionality of the needle itself (bending rigidity, bonding, penetration force, etc.), not on the accuracy or reliability of a diagnostic test.
- Key Metrics: The key metrics listed as "Not Applicable" (Sensitivity, Specificity, PPV, NPV) are standard metrics for evaluating the performance of diagnostic devices. Their absence further indicates this is not an IVD.
In summary, the SPROTTE® NRFit™ and Quincke NRFit™ needles are medical devices used for administering medication, which falls under the category of therapeutic devices, not in vitro diagnostics.
N/A
Intended Use / Indications for Use
The SPROTTE® NRFit™, Quincke NRFit™ needles are anesthesia conduction needles which are used to administer anesthetic agent to the subarachnoid space.
The device is intended for adult and pediatric patients.
Product codes (comma separated list FDA assigned to the subject device)
BSP
Device Description
The SPROTTE® NRFit™ and Quincke NRFit™ needles are anesthesia conduction needles. They consist of a needle/cannula (stainless steel, polycarbonate PC hub, optional epoxy resin glue), an introducer (stainless steel tubing, polycarbonate PC hub, optional epoxy resin glue), and a stylet (stainless steel tubing, polycarbonate PC knob, optional epoxy resin glue). Some models also include a retaining plate (polycarbonate PC) and a haemostylet (stainless steel). The devices are disposable and supplied sterile to the end user via Ethylene Oxide sterilization. They can also be supplied non-sterile for sterilization prior to use by repackagers/medical device manufacturers.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
subarachnoid space
Indicated Patient Age Range
The device is intended for adult and pediatric patients.
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
The performance tests for both the subject devices and predicate devices were conducted to comply with standards such as ISO 9626, ISO 7864, and ISO 80369-6. Testing was performed on devices ready to use after sterilization and after accelerated aging (1 year, 3 years, 5 years) to demonstrate substantial equivalence and shelf life.
Study Type/Key Results:
- Needle: stability test bending rigidity: The test procedure followed ISO/FDIS 9626:2016. The bending rigidity of the predicate device's needles and the subject device's needles is compliant with the standard. Conclusion: Substantially Equivalent.
- Needle: stability test bonding to hub: The test procedure followed ISO/FDIS 7864:2016. The acceptance criterion for the bond between hub and needle tube (pull-off force) is ≥22N. For both the subject and predicate devices, a force significantly higher than the target value had to be applied. Conclusion: Substantially Equivalent.
- Needle: Penetration force: The test procedure followed EN 13097. The subject device's needles as well as the predicate device's needles show identical penetration/insertion forces. Conclusion: Substantially Equivalent.
- 7864 9626 5.8 Stiffness: All tests were passed successfully with no significant differences between baseline and aged needles, nor between predicate and subject devices. Compliance to this section of the standard and a shelf life of 5 years is proven. Substantial Equivalence is demonstrated.
- 7864_4.10_Penetration_: All tests were passed successfully with no significant differences between baseline and aged needles, nor between predicate and subject devices. Compliance to this section of the standard and a shelf life of 5 years is proven. Substantial Equivalence is demonstrated.
- 7864 4.11 Hub-To-Needle: All tests were passed successfully with no significant differences between baseline and aged needles, nor between predicate and subject devices. Compliance to this section of the standard and a shelf life of 5 years is proven. Substantial Equivalence is demonstrated.
- 9626 5.9 Breakage: All tests were passed successfully with no significant differences between baseline and aged needles, nor between predicate and subject devices. Compliance to this section of the standard and a shelf life of 5 years is proven. Substantial Equivalence is demonstrated.
SPROTTE® NRFit™ Tested Devices (sample size 15 for each):
- SPROTTE® NRFit™: 120mm, 18G
- SPROTTE® NRFit™: 90mm, 19G
- SPROTTE® NRFit™: 90mm, 20G
- SPROTTE® NRFit™: 90mm, 21G
- SPROTTE® NRFit™: 150mm, 22G
- SPROTTE® NRFit™: 150mm, 24G
- SPROTTE® NRFit™: 150mm, 25G
- SPROTTE® NRFit™: 120mm, 27G
- SPROTTE® NRFit™: 90mm, 29G
SPROTTE® (Predicate) (sample size 15 for each):
- SPROTTE®: 120mm, 18G
- SPROTTE®: 90mm, 19G
- SPROTTE®: 90mm, 20G
- SPROTTE®: 90mm, 21G
- SPROTTE®: 150mm, 22G
- SPROTTE®: 150mm, 24G
- SPROTTE®: 150mm, 25G
- SPROTTE®: 120mm, 27G
- SPROTTE®: 90mm, 29G
Quincke NRFit™ Tested Devices (sample size 15 for each):
- Quincke NRFit™: 80mm, 20G
- Quincke NRFit™: 90mm, 22G
- Quincke NRFit™: 90mm, 24G
- Quincke NRFit™: 90mm, 25G
- Quincke NRFit™: 90mm, 27G
Quincke (Predicate) (sample size 5 for each):
- Quincke: 80mm, 20G
- Quincke: 90mm, 22G
- Quincke: 90mm, 24G
- Quincke: 90mm, 25G
- Quincke: 90mm, 27G
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 868.5150 Anesthesia conduction needle.
(a)
Identification. An anesthesia conduction needle is a device used to inject local anesthetics into a patient to provide regional anesthesia.(b)
Classification. Class II (performance standards).
0
Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is an abstract symbol that resembles three human profiles facing right, stacked on top of each other, with flowing lines beneath them.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
October 27, 2016
PAJUNK® GmbH Medizintechnologie Christian Quass Director Regulatory Affairs Karl-hall-str. 1 Geisingen, 78187 DE Germany
Re: K160295
Trade/Device Name: SPROTTE® NRFit™, Quincke NRFit™ Regulation Number: 21 CFR 868.5150 Regulation Name: Anesthesia Conduction Needle Regulatory Class: Class II Product Code: BSP Dated: September 22, 2016 Received: September 27, 2016
Dear Christian Quass:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration. listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical devicerelated adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in
1
the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
Tejashri Purohit-Sheth, M.D. Tejashri Purohit-Sheth, M.D. Clinical Deputy Director DAGRID/ODE/CDRH FOR
Tina Kiang, Ph.D. Acting Director Division of Anesthesiology. General Hospital, Respiratory, Infection Control, and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K160295
Device Name SPROTTE® NRFit™ and Quincke NRFit™
Indications for Use (Describe)
The SPROTTE® NRFit™, Quincke NRFit™ needles are anesthesia conduction needles which are used to administer anesthetic agent to the subarachnoid space.
The device is intended for adult and pediatric patients.
Type of Use (Select one or both, as applicable)
| Prescription Use (Part 21 CFR 801 Subpart D) |
|---|
| Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
Image /page/3/Picture/1 description: The image features the word "PAJUNK" in a bold, sans-serif font. The text is white and appears to have a slight blur or glow effect, giving it a soft appearance. The background is a solid teal color, providing a strong contrast that makes the text stand out. A registered trademark symbol is present to the right of the letter K.
Pioneering medical technology
510(k) Summary as required by 21 CFR 807.92(c).
Date of Preparation: October 27th 2016
Document Control Number: K160295
510(k) owner:
PAJUNK® GmbH Medizintechnologie Karl-Hall-Str. 1 78187 Geisingen Baden-Wuerttemberg, Germany Fon: +49(0)7704-9291-586 Fax: +49(0)7704-9291-605 Establishment Registration Number: 9611612
Submitter Information/ production site:
PAJUNK® GmbH Medizintechnologie Karl-Hall-Str. 1 78187 Geisingen Baden-Wuerttemberg, Germany Fon: +49(0)7704-9291-586 Fax: +49(0)7704-9291-605 Establishment Registration Number: 9611612
Contact:
Christian G. H. Quass Director Requlatory Affairs, Safety Officer Patricia Weisbrod Regulatory Affairs Manager Fon: +49(0)7704-9291-586 Fax: +49(0)7704-9291-605 E-Mail: christian.quass@pajunk.com E-Mail: patricia.weisbrod@pajunk.com
USA Contact:
PAJUNK MEDICAL SYSTEMS 6611 Bay Circle, Suite 140 Norcross, GA 30071 Phone +1 (888) 9PAJUNK (72-5865) Fax +1 (678) 514-3388
Establishment Registration Number: 3004076349
Contact
Marco Wohniq President PAJUNK® Medical Systems L.P. Phone: (770) 493-6832 Direct: (470) 448-4070 Cell: (770) 757-2449 Fax: (678) 514-3388 E-Mail: marco.wohnig@pajunk-usa.com
4
Image /page/4/Picture/1 description: The image shows the word "PAJUNK" in white letters against a green background. The letters are in a bold, sans-serif font. A registered trademark symbol is located to the right of the letter "K". The word appears to be a logo or brand name.
Pioneering medical technology
| Device Information: | |
|---|---|
| Device Name: | SPROTTE® NRFit™ and Quincke NRFit™ |
| Sterilization method: | Ethylene Oxide |
| disposable device, supplied sterile to the end | |
| user and non-sterile intended to be sterilized | |
| prior to use to repackagers/ medical device | |
| manufacturers | |
| Contract Sterilizer: | Sterigenics Germany GmbH |
| Kasteler straße 45 | |
| 65203 Wiesbaden | |
| Germany, Hessen | |
| Establishment Registration Number: | |
| 3002807090 | |
| Document Control Number | K160295 |
| Classification Name: | Anesthesia Conduction Needle |
| Classification Reference: | 21 CFR § 868.5150 |
| Product Code: | BSP |
| Establishment Registration Number: | 9611612 |
| Regulatory Class: | II |
| Panel: | Anesthesiology |
| Predicate Devices: | K911202 |
| ATRAUMATIC STANDARD SPROTTE | |
| NEEDLE | |
| (Owner: PAJUNK® GmbH Medizintechnologie) | |
| K040965 | |
| (Owner: PAJUNK® GmbH Medizintechnologie) | |
| PAJUNK TUOHY NEEDLES, QUINCKE | |
| NEEDLES, CHIBA NEEDLES & CRAWFORD |
PAJUNK® GmbH Medizintechnologie is submitting this 510(k) for SPROTTE® NRFit™ and Quincke NRFit™ needles for spinal anaesthesia.
NEEDLES
The intended use as well as the basic technical description of the needles which is relevant to clinical use is identical to the predicate devices and has been cleared in 510(k)s sent in earlier by the sponsor.
The clinical technique, the indications for use, the technical specification, the materials used, the sterility status (validation and sterility assurance level) as the biocompatibility status is identical. None of these is affected by the altered hub as it is subject to this submission.
5
Image /page/5/Picture/1 description: The image features the word "PAJUNK" in a bold, sans-serif font. The letters are white, and they stand out against a teal background. A small registered trademark symbol is located to the right of the letter "K".
12.1 Identification of Predicate devices
In this section SPROTTE® NRFit™ and Quincke NRFit™ needles for spinal anaesthesia are compared to the predicate device.
In order to avoid confusion and to make the information more readable, the predicate devices shall be identified as Predicate Device I (which is for the SPROTTE® NRFit™) and Predicate Device II (which is for the Quincke NRFit™) since the Subject devices are identical in Indications for use while the predicates show differences in wording.
Predicate Device I
The predicate device for the SPROTTE® NRFit™ lumbar puncture needles is:
- K911202 ATRAUMATIC STANDARD SPROTTE NEEDLE (Owner: PAJUNK® GmbH Medizintechnologie)
Predicate Device II
The predicate device for the Quincke NRFit™ lumbar puncture needles is:
- K040965 PAJUNK TUOHY NEEDLES, QUINCKE NEEDLES, CHIBA NEEDLES & -CRAWFORD NEEDLES (Owner: PAJUNK® GmbH Medizintechnologie)
12.2 Determination of Substantial Equivalence
12.2.1 Intended Use
Intended Use Subject Device
The SPROTTE® NRFit™, Quincke NRFit™ needles are anesthesia conduction needles which are used to administer anesthetic agent to the subarachnoid space.
Intended Use K911202 (Predicate Device I)
The Standard SPROTTE® Needle is an anesthesia conduction needle which is used to administer anesthetic agent to the subarachnoid space.
Intended Use K040965 (Predicate Device II)
Pajunk's anesthesia conduction needles - Tuohy, Quincke, Chiba, and Crawford - are intended for the transient delivery of anesthetics to provide regional anesthesia or to facilitate placement of an epidural catheter.
Discussion of differences
For the SPROTTE® NRFit™ spinal anaesthesia needles the indications for use is exactly the same as in K911202.
For the Quincke NRFit™ needles for spinal anaesthesia the indication for use is covered by the indications for use as given in the predicate K040965.
Rationale: K040965 covers needles for regional anaesthesia (spinal and epidural) and placement of epidural catheters. In the predicate's K040965 indications for use instead of the more specific term "subarachnoid" the wider term "regional anaesthesia" is used. So the term used in the subject device's submission shall be preferred.
6
PAJUNK®
Pioneering medical technology
Furthermore the predicate device allows placement of a catheter which shall not be covered by the subject device. The Quincke Needle subject to this Premarket Notification is intended for single shot spinal anaesthesia. The anatomical region of the body is absolutely the same. Furthermore Quincke needles (and SPROTTE® needles) are state of the art in spinal puncture for application of anesthetics as well as harvesting spinal fluid. The anatomical regions are absolutely identical.
Conclusion: Substantially Equivalent
The predicate device as well as the subject device only differs in design of the hub. This difference does not have any impact on the performance tests listed below due to the fact, that the materials used, the manufacturing processes employed and the techniques described are absolutely identical.
Technical Description
12.2.2.1 Technical Description SPROTTE
| Materials used in SPROTTE® NRFit™ spinal anaesthesia needles: | Predicate Device | |||||
|---|---|---|---|---|---|---|
| NAME OF COMPONENT | MATERIAL | BODY CONTACT | MATERIAL K911202 | |||
| 01 | Needle/ | |||||
| cannula | Tubing | Stainless Steel 1.4301 | ||||
| (X5CrNi18-10), AISI 304 | ||||||
| (V2A) | Direct, limited | Stainless Steel 1.4301 | ||||
| (X5CrNi18-10), AISI 304 | ||||||
| (V2A) | ||||||
| Hub | Polycarbonate PC | Indirect, limited | Polycarbonate PC | |||
| Optional: | ||||||
| Glue | Epoxy resin | No contact at all | Epoxy resin | |||
| 02 | Introducer | Tubing | Stainless Steel 1.4301 | |||
| (X5CrNi18-10), AISI 304 | ||||||
| (V2A) | Direct, limited | Stainless Steel 1.4301 | ||||
| (X5CrNi18-10), AISI 304 | ||||||
| (V2A) | ||||||
| Hub | Polycarbonate PC - | No contact at all | Polycarbonate PC | |||
| Optional: | ||||||
| Glue | Epoxy resin | No contact at all | Epoxy resin | |||
| 03 | Stylet | Tubing | Stainless Steel 1.4301 | |||
| (X5CrNi18-10), AISI 304 | ||||||
| (V2A) | Direct, limited | Stainless Steel V2A | ||||
| Knob | Polycarbonate PC - | No contact at all | Poliamide | |||
| Optional: | ||||||
| Glue | Epoxy resin | No contact at all | Epoxy resin | |||
| 04 | Retaining | |||||
| plate | Plate | Polycarbonate PC - | No contact at all | Polycarbonate GE Lexan | ||
| 164R | ||||||
| 05 | Haemostylet | stylet | Stainless Steel 1.4301 | |||
| (X5CrNi18-10), AISI 304 | ||||||
| (V2A) | Direct, limited | Stainless Steel V2A |
7
Image /page/7/Picture/1 description: The image shows the word "PAJUNK" in white letters against a teal background. The letters are bold and slightly blurred, giving them a soft, glowing effect. A small registered trademark symbol is visible to the right of the letter "K".
Pioneering medical technology
Based on substantial equivalence testing listed below the following devices are subject to this premarket notification and shall be cleared:
SPROTTE® NRFit™ in a range from 18G to 29G at a rage of length from 50mm to 150mm.
Dimensions intended in the subject devices Premarket Notification K160195:
Length: 50mm to 150mm
Diameter: 18G - 29G
12.2.2.1.1 Discussion of differences
-
The material of the hub has been altered in 1994. Before that date Polycarbonate PC xxx has been used which then was switched to Polycarbonate PC - yyy. The biocompatibility test reports provided for the SPROTTE contain needles equipped with hubs made from yyy. However, the base substance for both is Polycarbonate Medical Grade. xxx has a significant higher flow pattern index.
-
The material of the stylet´s knob has been switched from Poliamide zzz to Polycarbonate PC yyy. Since the knob does not have any patient contact this change is non-significant to form, fit and function.
| Materials used in Quincke NRFit™ spinal anaesthesia needles: | Predicate Device | ||
|---|---|---|---|
| MATERIAL K190195 | MATERIAL | ||
| BODY CONTACT | MATERIAL K040965 | ||
| 01 | Needle/ | ||
| cannula | Tubing | ||
| Stainless Steel | |||
| Direct, limited | Stainless steel | ||
| Hub | |||
| Polycarbonate PC - | |||
| Indirect, limited | Polycarbonate | ||
| Optional: Glue | |||
| Epoxy resin | |||
| No contact at all | Epoxy Resin | ||
| 02 | Introducer | Tubing | |
| Stainless Steel | |||
| Direct, limited | Stainless steel | ||
| Hub | |||
| Polycarbonate PC - | |||
| No contact at all | Polycarbonate | ||
| Optional: Glue | |||
| Epoxy resin | |||
| No contact at all | Epoxy Resin | ||
| 03 | Stylet | Tubing | |
| Stainless Steel | |||
| Direct, limited | Stainless steel | ||
| Knob | |||
| Polycarbonate PC - | |||
| No contact at all | Polycarbonate | ||
| Optional: Glue | |||
| Epoxy resin | |||
| No contact at all | Epoxy Resin | ||
| 04 | Retaining | ||
| plate | Plate | ||
| Polycarbonate PC | |||
| No contact at all | Polycarbonate | ||
| 05 | Fixation Clip | Clip | |
| Polycarbonate PC - | |||
| No contact at all | Polycarbonate | ||
| 05 | Haemostylet | stylet | |
| Stainless Steel | |||
| Direct, limited | Stainless Steel V2A |
12.2.2.2 Technical Description Quincke
8
Image /page/8/Picture/1 description: The image shows the word "PAJUNK" in white letters against a teal background. The letters are bold and slightly blurred, giving them a soft appearance. A small registered trademark symbol is visible to the upper right of the letter "K".
Based on substantial equivalence testing listed below the following devices are subject to this premarket notification and shall be cleared:
Quincke NRFit™ in a range from 20G to 27G at a rage of length from 50mm to 120mm.
12.2.2.3 Devices under test
Both, the subject devices as well as the predicate devices have been tested ready to use right after sterilization and have been subject to testing after accelerated aging (1year, 3years, 5years) in order to demonstrate substantial equivalence and Shelf Life.
For demonstrating substantial equivalence the items listed below have been compared:
SPROTTE® NRFfit™
| # | Devices/ Materials | Item-number | LOT | Length [mm] | Gauge | sample size |
|---|---|---|---|---|---|---|
| 1 | SPROTTE® NRFit™ | 321163-30F | 1116 | 120 | 18 | 15 |
| 2 | SPROTTE® NRFit™ | 321163-31C | 1116 | 90 | 19 | 15 |
| 3 | SPROTTE® NRFit™ | 321163-31B | 1116 | 90 | 20 | 15 |
| 4 | SPROTTE® NRFit™ | 321163-31A | 1116 | 90 | 21 | 15 |
| 5 | SPROTTE® NRFit™ | 141163-30C | 1116 | 150 | 22 | 15 |
| 6 | SPROTTE® NRFit™ | 131163-30A | 1116 | 150 | 24 | 15 |
| 7 | SPROTTE® NRFit™ | 261163-29A | 1116 | 150 | 25 | 15 |
| 8 | SPROTTE® NRFit™ | 231163-27A | 1116 | 120 | 27 | 15 |
| 9 | SPROTTE® NRFit™ | 501163-28A | 1116 | 90 | 29 | 15 |
SPROTTE®
| # | Devices/ Materials | Item-number | LOT | Length [mm] | Gauge | sample size |
|---|---|---|---|---|---|---|
| 1 | SPROTTE® | 321151-30F | 1116 | 120 | 18 | 15 |
| 2 | SPROTTE® | 321151-31C | 1116 | 90 | 19 | 15 |
| 3 | SPROTTE® | 321151-31B | 1116 | 90 | 20 | 15 |
| 4 | SPROTTE® | 321151-31A | 1116 | 90 | 21 | 15 |
| 5 | SPROTTE® | 141151-30C | 1116 | 150 | 22 | 15 |
| 6 | SPROTTE® | 141151-30A | 1116 | 150 | 24 | 15 |
| 7 | SPROTTE® | 061151-29A | 1116 | 150 | 25 | 15 |
| 8 | SPROTTE® | 231151-27A | 1116 | 120 | 27 | 15 |
| 9 | SPROTTE® | 501151-28A | 1116 | 90 | 29 | 15 |
Quincke NRFit™
| # | Devices/ Materials | Item-number | LOT | Length [mm] | Gauge | sample size |
|---|---|---|---|---|---|---|
| 1 | Quincke NRFit™ | 1163-3G080 | 1116 | 80 | 20 | 15 |
| 2 | Quincke NRFit™ | 1163-3E090 | 1116 | 90 | 22 | 15 |
| 3 | Quincke NRFit™ | 1163-7Y090 | 1116 | 90 | 24 | 15 |
| 4 | Quincke NRFit™ | 1163-7C090 | 1116 | 90 | 25 | 15 |
| 5 | Quincke NRFit™ | 1163-7B090 | 1116 | 90 | 27 | 15 |
Quincke
| # | Devices/ Materials | Item-number | LOT | Length [mm] | Gauge | sample size |
|---|---|---|---|---|---|---|
| 1 | Quincke | 1149-3G080 | 1116 | 80 | 20 | 5 |
| 2 | Quincke | 1149-3E090 | 1116 | 90 | 22 | 5 |
| 3 | Quincke | 1149-7Y090 | 1116 | 90 | 24 | 5 |
| 4 | Quincke | 1149-7C090 | 1116 | 90 | 25 | 5 |
| 5 | Quincke | 1149-7B090 | 1116 | 90 | 27 | 5 |
9
12.2.3.1 Performance Testing: Summary
The predicate device as well as the subject device only differs in design of the hub.
This difference does not have any impact on the performance tests listed below. Therefore performance testing is still valid and applies to both, subject device and predicate device.
The performance tests have been accomplished in order to comply with the standards listed below (even though 6-366 and 6-362 are not directly linked with Product Code BSP):
| Recognition-# | Standard Number | Title |
|---|---|---|
| 6-366 | ISO 9626 | Stainless steel needle tubing for the manufacture of |
| medical devices - Requirements and test methods | ||
| 6-362 | ISO 7864 | Sterile hypodermic needles for single use - |
| Requirements and test methods | ||
| 5-108 | ISO 80369-6 | Small bore connectors for liquids and gases in |
| healthcare applications - Part 6: Connectors for | ||
| neuraxial applications. |
Stability test Bonding-to-Hub has to be conducted in order to compare the stability of the LUER Hub with the stability of the NRFit™ hub.
Furthermore compliance of the needle hub with ISO 80369-6 has to be proven.
Standard testing regarding the remaining sections of the recognized performance standards can be conducted using either the predicate device or the subject device because the needle tubing is absolutely identical.
Needle: stability test bending rigidity
Reason for test: The needle has to demonstrate bending stability and resistance against breakage in order to resist forces reasonably assumed to the needle in situ under the defined intended use
Procedure of test: The test procedure is defined by international standard ISO/FDIS 9626:2016 Stainless steel needle tubing for manufacture of medical devices.
Pass/ Fail criteria: The acceptance criterion of bending rigidity for the cannula is defined in above mentioned standard.
Results: The bending rigidity of the predicate device 's needles and the subject device's needles is compliant with the standard.
Conclusion: Substantially Equivalent
10
Needle: stability test bonding to hub
Reason for test: The needle has to demonstrate stability at the bonding of the hub in order to resist forces reasonably assumed to be applied to the needle in situ under the defined intended use.
Procedure of test: The test procedure is defined by international standard ISO/FDIS 7864:2016 Sterile hypodermic needles for single use
Pass/ Fail criteria: The acceptance criterion for the bond between hub and needle tube (pull-off force) is ≥22N.
Results: For the needles of the subject device and the needles of the predicate device a force significantly higher than the target value has to be applied. Therefore the predicate device 's needles as well as the subject device 's needles are substantially equivalent.
Conclusion: Substantially Equivalent
Needle: Penetration force
Reason for test: The needles have to demonstrate less trauma when applied with the patient under the intended use. ISO/FDIS 7864:2016 Sterile hypodermic needles for single use recommends penetration force testing only without giving a normative test method.
Procedure of test: According to international European standard EN 13097.
Pass/ Fail criteria: -none- objective comparison only.
Results: The subject device's needles as well as the predicate device´s needles show identical penetration/ insertion forces.
Conclusion: Substantially Equivalent
2.3.2 Performance Testing: Comparison of test reports
2.3.2.1 7864 9626 5.8 Stiffness
All tests are passed successfully. There are no significant differences between the baseline and the aged needles nor are there significant differences between the predicate device and the subject device.
Compliance to this section of the standard and Shelf life of 5 years is proven.
Substantial Equivalence is demonstrated.
12.2.3.2.2 7864_4.10_Penetration_
All tests are passed successfully. There are no significant differences between the baseline and the aged needles nor are there significant differences between the predicate device and the subject device.
Compliance to this section of the standard and Shelf life of 5 years is proven.
Substantial Equivalence is demonstrated.
12.2.3.2.3 7864 4.11 Hub-To-Needle
All tests are passed successfully. There are no significant differences between the baseline and the aged needles nor are there significant differences between the predicate device and the subject device.
Compliance to this section of the standard and Shelf life of 5 years is proven.
Substantial Equivalence is demonstrated.
11
Image /page/11/Picture/1 description: The image shows the word "PAJUNK" in white letters against a teal background. The letters are bold and sans-serif. A small registered trademark symbol is located to the right of the letter "K".
2.3.2.4 9626 5.9 Breakage
This section summarizes the results of standard testing for the SPROTTE® NRFit™ and SPROTTE according to ISO/ FDIS 9626:2016 Stainless steel needle tubing for the manufacture of medical devices -Requirements and test methods Clause 5.9 Resistance to breakage
All tests are passed successfully. There are no significant differences between the baseline and the aged needles nor are there significant differences between the predicate device and the subject device.
Compliance to this section of the standard and Shelf life of 5 years is proven.
Substantial Equivalence is demonstrated.
2.4 Sterilization
The predicate device as well as the subject device only differs in design of the hub. This difference does not have any impact on Sterilization. Therefore the Sterilization is still valid.
The contract sterilizer and the sterilizing process are identical to the contract sterilizer and the sterilizing process used for all PAJUNK® - manufactured devices which are already cleared for market or exempt.
Sterilization parameters are
| SAL | 10-6 |
|---|---|
| Type of gas | Ethylene Oxide 99,99% |
| Exposure time | 300 min. |
| Aeration method | evacuation |
| 2 airwashes | |
| Aeration period | residual EtO-gas is removed in circulating |
| air at 40° C (±5) for at least 48h |
Sterilization has been validated according to ISO 11135-1 Overkill Approach (1 sublethal cycle, 2 half cycle, 1 full cycle)
Residuals of EO and ECH are in compliance with ISO 10993-7.
Cleaning and Sterilization method, which ensures an SAL of 10° as well as compliance with limits for chemical burden, bioburden, pyroburden (i.e. LAL and the rabbit pyrogen test) and EtOresiduals as well as shelf life have been validated.
The limits listed below are met by each device:
The needles are also available in bulk non sterile. If appropriately packed and sterilized with Ethyleneoxide according to the parameters above the technological parameters remain unchanged. However, final responsibility for sterilization remains with the customer of needles purchased bulk non-sterile.
12
2.5 Shelf Life
The predicate device as well as the subject device only differs in design of the hub. This difference does not have any impact on Shelf Life. Therefore the Shelf Life is still valid.
Efficacy of sterile product´s lifecycle has been validated using similar products and worst case devices.
Sterility tests have been performed using worst case devices with similar characteristics made from identical material after 5 years. The devices were found to be sterile after 5 years, the sterile barrier system is efficient.
Performance of the essential performance of the device (LUER/ NRFit™ connection, stability of bonding connections, catheter's tensile strength, needle 's bending rigidity) has been tested with real time aged needles and catheters made from identical material employing identical processes and those are found to work properly. There is no decrease in performance after 5 years.
Shelf-life is set to 5 years.
2.6 Biocompatibility:
The predicate device as well as the subject device only differs in design of the hub. The manufacturing processes of the subject device and the predicate device are identical. The difference in design does not have any impact on Biocompatibility of the device. Therefore the biocompatibility testing conducted with the predicate device is still valid.
All devices comply with ISO 10993-1, 2nd and 3rd edition.
The components of the SPROTTE® NRFit™ and Quincke NRFit™ are identical to the components of the SPROTTE and Quincke as they were approved/cleared in K911202 and K040965 in formulation, processing, and sterilization, and no other chemicals have been added (e.g., plasticizers, fillers, color additives, cleaning agents, mold release agents, etc.).
The components of the subject devices SPROTTE® NRFit™ and Quincke NRFit™ and the components of the predicate devices SPROTTE and Quincke are identical to the components of the worst case device which has been tested in formulation, processing, and sterilization, and no other chemicals have been added (e.q., plasticizers, fillers, cleaning agents, mold release agents, etc.).
The tests listed below have been conducted and accomplished successfully by the worst case device:
- . In vitro Cytotoxicity ISO 10993-5
- . Irritation ISO 10993-10
- . Sensitization ISO 10993-10
- . Acute systemic toxicity
- . Hemocompatibility
Therefore and based upon sterilization validation and residuals validation the devices are considered to be biocompatible.
13
Image /page/13/Picture/1 description: The image shows the word "PAJUNK" in white letters against a teal background. The letters are bold and sans-serif. A small registered trademark symbol is located to the right of the letter "K".
3. Conclusion
All tests are passed successfully. There are no significant differences between the baseline and the aged needles Subject device and Predicate device nor are there significant differences between the predicate device and the subject device in performance.
Compliance to international standards and Shelf life of 5 years is proven.
The conclusions drawn from the nonclinical tests demonstrate that the device is as safe, as effective, and performs as well as the legally marketed device identified.